blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3634443

EP3634443 - MICROBIOME BIOMARKERS OF IMMUNOTHERAPY RESPONSIVENESS: DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES THEREOF [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  25.01.2024
Database last updated on 27.07.2024
FormerExamination is in progress
Status updated on  19.11.2021
FormerRequest for examination was made
Status updated on  13.03.2020
FormerThe international publication has been made
Status updated on  15.12.2018
Most recent event   Tooltip19.06.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
The University of Chicago
5801 South Ellis Avenue
Chicago, IL 60637 / US
[2020/16]
Inventor(s)01 / GAJEWSKI, Thomas F.
c/o The University of Chicago
5801 S. Ellis Avenue
Chicago, Illinois 60637 / US
02 / LUKE, Jason
c/o The University of Chicago
5801 S. Ellis Avenue
Chicago, Illinois 60637 / US
03 / BAO, Riyue
c/o The University of Chicago
5801 S. Ellis Avenue
Chicago, Illinois 60637 / US
04 / MATSON, Vyara
c/o The University of Chicago
5801 S. Ellis Avenue
Chicago, Illinois 60637 / US
05 / FESSLER, Jessica
c/o The University of Chicago
5801 S. Ellis Avenue
Chicago, Illinois 60637 / US
 [2020/16]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[2020/16]
Application number, filing date18812758.305.06.2018
[2020/16]
WO2018US36052
Priority number, dateUS201762515366P05.06.2017         Original published format: US 201762515366 P
US201762577454P26.10.2017         Original published format: US 201762577454 P
[2020/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018226690
Date:13.12.2018
Language:EN
[2018/50]
Type: A1 Application with search report 
No.:EP3634443
Date:15.04.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 13.12.2018 takes the place of the publication of the European patent application.
[2020/16]
Search report(s)International search report - published on:US13.12.2018
(Supplementary) European search report - dispatched on:EP17.02.2021
ClassificationIPC:A61K35/741, A61K35/744, A61K35/745, A61K35/747, A61K39/395, A61K45/06, C07K16/28, A61P35/00, G01N33/50
[2024/07]
CPC:
C07K16/2827 (EP,US); A61K35/745 (EP,US); A61K35/741 (EP);
A61K35/744 (EP); A61K35/747 (EP,US); A61K39/395 (EP);
A61K45/06 (EP); A61K9/0014 (EP); A61K9/0019 (EP);
A61K9/0031 (EP); A61K9/12 (EP); A61P35/00 (EP,US);
C07K16/2818 (EP,US); A61K2039/505 (EP); A61K38/00 (EP) (-)
C-Set:
A61K35/741, A61K2300/00 (EP);
A61K35/744, A61K2300/00 (EP);
A61K35/745, A61K2300/00 (EP);
A61K35/747, A61K2300/00 (EP)
Former IPC [2021/12]A61K35/741, A61K39/395, A61K45/06, A61K9/00, A61P35/00
Former IPC [2020/16]A61K35/741, A61K39/395, A61K45/06, A61K9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/16]
TitleGerman:MIKROBIOMBIOMARKER DES ANSPRECHENS AUF EINE IMMUNTHERAPIE: DIAGNOSTISCHE, PROGNOSTISCHE UND THERAPEUTISCHE VERWENDUNGEN DAVON[2020/16]
English:MICROBIOME BIOMARKERS OF IMMUNOTHERAPY RESPONSIVENESS: DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC USES THEREOF[2020/16]
French:BIOMARQUEURS DU MICROBIOME DE LA RÉACTIVITÉ À L'IMMUNOTHÉRAPIE : UTILISATIONS DIAGNOSTIQUES, PRONOSTIQUES ET THÉRAPEUTIQUES DE CEUX-CI[2020/16]
Entry into regional phase12.12.2019National basic fee paid 
12.12.2019Search fee paid 
12.12.2019Designation fee(s) paid 
12.12.2019Examination fee paid 
Examination procedure12.12.2019Examination requested  [2020/16]
20.09.2021Amendment by applicant (claims and/or description)
22.11.2021Despatch of a communication from the examining division (Time limit: M06)
01.06.2022Reply to a communication from the examining division
12.07.2023Despatch of a communication from the examining division (Time limit: M02)
22.09.2023Reply to a communication from the examining division
26.01.2024Communication of intention to grant the patent
18.06.2024Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
Fees paidRenewal fee
15.06.2020Renewal fee patent year 03
14.06.2021Renewal fee patent year 04
13.05.2022Renewal fee patent year 05
31.03.2023Renewal fee patent year 06
13.05.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2016063263  (ROUSSY INST GUSTAVE [FR]) [I] 1-15 * pages 4-5, 24; page 4 - page 5 *;
 [XI]  - A. SIVAN ET AL, "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy", SCIENCE, US, (20151127), vol. 350, no. 6264, doi:10.1126/science.aac4255, ISSN 0036-8075, pages 1084 - 1089, XP055310361 [X] 10 * abstract, fig. 1-3; last par on page 1089 * [I] 1-9,11-15

DOI:   http://dx.doi.org/10.1126/science.aac4255
 [I]  - M. VETIZOU ET AL, "Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota", SCIENCE, US, (20151105), vol. 350, no. 6264, doi:10.1126/science.aad1329, ISSN 0036-8075, pages 1079 - 1084, XP055691620 [I] 1-15 * page 5, last par. *

DOI:   http://dx.doi.org/10.1126/science.aad1329
International search[A]US2016235792  (BERRY DAVID [US], et al) [A] 1 * ; para [0838] *;
 [X]WO2016196605  (UNIV CHICAGO [US]) [X] 1-30 * ; Abstract; pg 2, In 9-31; pg 3, In 22-32; pg 6, In 6-23; pg 8, In 15-17; pg 9,1 n 14-18; pg 22, In 6-17; pg 35, In 23-33 *;
 [A]  - PITT et al., "Fine-Tuning Cancer Immunothorapy: Optimizing the Gut Microbiome", Cancer Research, (20160815), vol. 76, no. 16, pages 1 - 6, XP055522231 [A] 1 * ; pg 4, col 2, para 2 *

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-16-0448
by applicantWO8801649
 US4816567
 US4946778
 US5260203
 US8449878
 WO2016063263
 WO2016196605
    - HODI, F. S. et al., The New England Journal of Medicine, (20100000), vol. 363, pages 711 - 723
    - WOLCHOK, J. D. et al., The New England Journal of Medicine, (20130000), vol. 369, pages 122 - 133
    - TUMEH et al., Nature, (20140000), vol. 515, pages 568 - 571
    - SPRANGER et al., Science Translational Medicine, (20130000), vol. 5, pages 200 - 116
    - JI et al., Cancer Immunology, Immunotherapy, (20120000), vol. 61, pages 1019 - 1031
    - GAJEWSKI et al., Cancer Journal, (20100000), vol. 16, pages 399 - 403
    - VETIZOU et al., SCIENCE, (20150000), vol. 350, no. 6264, pages 1079 - 1084
    - CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 3242
    - CHOTHIA, C.LESK, A. M., J. Mol. Biol., (19870000), vol. 196, pages 901 - 917
    - CHOTHIA, C. et al., Nature, (19890000), vol. 342, pages 878 - 883
    - KOHLERMILSTEIN, Nature, (19750000), vol. 256, pages 495 - 499
    - MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597
    - HUDSON et al., Nat. Med., (20030000), vol. 9, pages 129 - 134
    - TOPALIAN, S. L. et al., Journal of Clinical Oncology, (20140000), vol. 32, pages 1020 - 1030
    - TOPALIAN, S. L. et al., The New England Journal of Medicine, (20120000), vol. 366, pages 2443 - 2454
    - J. G. CAPORASO et al., "Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms", The ISME journal, (20120000), vol. 6, doi:10.1038/ismej.2012.8, pages 1621 - 1624, XP055341618

DOI:   http://dx.doi.org/10.1038/ismej.2012.8
    - S. L. TOPALIAN et al., "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer", The New England journal of medicine, (20120000), vol. 366, doi:10.1056/NEJMoa1200690, pages 2443 - 2454, XP055098235

DOI:   http://dx.doi.org/10.1056/NEJMoa1200690
    - C. ROBERT et al., "Pembrolizumab versus Ipilimumab in Advanced Melanoma", The New England journal of medicine, (20150000), vol. 372, pages 2521 - 2532
    - A. SIVAN et al., "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy", Science, (20150000), vol. 350, doi:10.1126/science.aac4255, pages 1084 - 1089, XP055310361

DOI:   http://dx.doi.org/10.1126/science.aac4255
    - R. DAILLERE et al., "Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects", Immunity, (20160000), vol. 45, pages 931 - 943
    - N. IIDA et al., "Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment", Science (New York, N.Y., (20130000), vol. 342, doi:10.1126/science.1240527, pages 967 - 970, XP055110345

DOI:   http://dx.doi.org/10.1126/science.1240527
    - K. ATARASHI et al., "Induction of colonic regulatory T cells by indigenous Clostridium species", Science (New York, N.Y., (20110000), vol. 331, doi:10.1126/science.1198469, pages 337 - 341, XP055178447

DOI:   http://dx.doi.org/10.1126/science.1198469
    - J. L. ROUNDS. K. MAZMANIAN, "Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota", Proceedings of the National Academy of Sciences of the United States of America, (20100000), vol. 107, doi:10.1073/pnas.0909122107, pages 12204 - 12209, XP055088747

DOI:   http://dx.doi.org/10.1073/pnas.0909122107
    - N. GEVA-ZATORSKY et al., "Mining the Human Gut Microbiota for Immunomodulatory Organisms", Cell, (20170000), vol. 168, pages 928 - 943
    - J. G. CAPORASO et al., "Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample", Proceedings of the National Academy of Sciences of the United States of America, (20110000), vol. 108, doi:10.1073/pnas.1000080107, pages 4516 - 4522, XP055252625

DOI:   http://dx.doi.org/10.1073/pnas.1000080107
    - J. G. CAPORASO et al., "QIIME allows analysis of high-throughput community sequencing data", Nat Methods, (20100000), vol. 7, doi:10.1038/nmeth.f.303, pages 335 - 336, XP055154026

DOI:   http://dx.doi.org/10.1038/nmeth.f.303
    - D. MCDONALD, "An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea", ISME J, (20120000), vol. 6, pages 610 - 618
    - J. G. CAPORASO et al., "PyNAST: a flexible tool for aligning sequences to a template alignment", Bioinformatics, (20100000), vol. 26, pages 266 - 267
    - Q. WANGG. M. GARRITYJ. M. TIEDJEJ. R. COLE, "Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy", Appl Environ Microbiol, (20070000), vol. 73, doi:10.1128/AEM.00062-07, pages 5261 - 5267, XP055154006

DOI:   http://dx.doi.org/10.1128/AEM.00062-07
    - N. SEGATA et al., "Metagenomic microbial community profiling using unique clade-specific marker genes", Nat Methods, (20120000), vol. 9, doi:10.1038/nmeth.2066, pages 811 - 814, XP055547360

DOI:   http://dx.doi.org/10.1038/nmeth.2066
    - C. HUMAN, "Microbiome Project, A framework for human microbiome research", Nature, (20120000), vol. 486, pages 215 - 221
    - M. C. COLLADOM. DERRIENE. ISOLAURIW. M. DE VOSS. SALMINEN, "Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly", Applied and environmental microbiology, (20070000), vol. 73, pages 7767 - 7770
    - J. JUNICKM. BLAUT, "Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene", Applied and environmental microbiology, (20120000), vol. 78, pages 2613 - 2622
    - E. MALINEN, A. KASSINEN, T. RINTTILA, A. PALVA, "Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria", Microbiology (Reading, England, (20030000), vol. 149, pages 269 - 277, XP002451760
    - T. MATSUKIK. WATANABER. TANAKAH. OYAIZU, "Rapid identification of human intestinal bifidobacteria by 16S rRNA-targeted species- and group-specific primers", FEMS microbiology letters, (19980000), vol. 167, pages 113 - 121
    - A. KASSINEN et al., "The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects", Gastroenterology, (20070000), vol. 133, doi:10.1053/j.gastro.2007.04.005, pages 24 - 33, XP022135951

DOI:   http://dx.doi.org/10.1053/j.gastro.2007.04.005
    - I. U. RATHNAYAKE, M. HARGREAVES, F. HUYGENS, "Genotyping of Enterococcus faecalis Enterococcus faecium isolates by use of a set of eight single nucleotide polymorphisms", Journal of clinical microbiology, (20110000), vol. 49, pages 367 - 372
    - T. RINTTILAA. KASSINENE. MALINENL. KROGIUSA. PALVA, "Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR", Journal of applied microbiology, (20040000), vol. 97, doi:10.1111/j.1365-2672.2004.02409.x, pages 1166 - 1177, XP008128526

DOI:   http://dx.doi.org/10.1111/j.1365-2672.2004.02409.x
    - Z. SUN et al., "Locked nucleic acid pentamers as universal PCR primers for genomic DNA amplification", PloS one, (20080000), vol. 3, page e3701
    - K. MATSUDA, "Establishment of an analytical system for the human fecal microbiota based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules", Applied and environmental microbiology, (20090000), vol. 75, doi:10.1128/AEM.01843-08, pages 1961 - 1969, XP008128527

DOI:   http://dx.doi.org/10.1128/AEM.01843-08
    - P. LOUIS, S. I. MCCRAE, C. CHARRIER, H. J. FLINT, "Organization of butyrate synthetic genes in human colonic bacteria: phylogenetic conservation and horizontal gene transfer", FEMS microbiology letters, (20070000), vol. 269, doi:10.1111/j.1574-6968.2006.00629.x, pages 240 - 247, XP009137661

DOI:   http://dx.doi.org/10.1111/j.1574-6968.2006.00629.x
    - X. W. HUIJSDENS et al., "Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR", Journal of clinical microbiology, (20020000), vol. 40, pages 4423 - 4427
    - J. TONGC. LIUP. SUMMANENH. XUS. M. FINEGOLD, "Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples", Anaerobe, (20110000), vol. 17, pages 64 - 68
    - H. YAMPARA-IQUISEG. ZHENGJ. E. JONESC. A. CARSON, "Use of a Bacteroides thetaiotaomicron-specific alpha-1-6, mannanase quantitative PCR to detect human faecal pollution in water", Journal of applied microbiology, (20080000), vol. 105, pages 1686 - 1693
    - S. J. SONG et al., "Cohabiting family members share microbiota with one another and with their dogs", Elife, (20130000), vol. 2, page e00458
    - C. G. BUFFIE et al., "Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis", Infect Immun, (20120000), vol. 80, pages 62 - 73
    - S. ANDREWS, "FastQC: A quality control application for high throughput sequence data", Babraham Institute, (20160000), URL: http://www.bioinformatics.babraham.ac.uk/projects/fastqc
    - N. L. BRAYH. PIMENTELP. MELSTEDL. PACHTER, "Near-optimal probabilistic RNA-seq quantification", Nature biotechnology, (20160000), vol. 34, pages 525 - 527
    - C. SONESONM. I. LOVEM. D. ROBINSON, "Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences", F1000Res, (20150000), vol. 4, page 1521
    - A. TARASOVA. J. VILELLAE. CUPPENI. J. NIJMANP. PRINS, "Sambamba: fast processing of NGS alignment formats", Bioinformatics, (20150000), vol. 31, pages 2032 - 2034
    - G. A. VAN DER AUWERA et al., "From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline", Curr Protoc Bioinformatics, (20130000), vol. 43, no. 11, 10, pages 11 - 33
    - K. CIBULSKIS et al., "Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples", Nature biotechnology, (20130000), vol. 31, doi:10.1038/nbt.2514, pages 213 - 219, XP055256219

DOI:   http://dx.doi.org/10.1038/nbt.2514
    - C. GENOMES PROJECT et al., "A global reference for human genetic variation", Nature, (20150000), vol. 526, pages 68 - 74
    - W. FU et al., "Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants", Nature, (20130000), vol. 493, doi:10.1038/nature11690, pages 216 - 220, XP055422906

DOI:   http://dx.doi.org/10.1038/nature11690
    - M. LEK et al., "Analysis of protein-coding genetic variation in 60,706 humans", Nature, (20160000), vol. 536, doi:10.1038/nature19057, pages 285 - 291, XP055650516

DOI:   http://dx.doi.org/10.1038/nature19057
    - K. WANGM. LIH. HAKONARSON, "ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data", Nucleic Acids Res, (20100000), vol. 38, page e164
    - C. BLANK et al., "PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells", Cancer research, (20040000), vol. 64, doi:10.1158/0008-5472.CAN-03-3259, pages 1140 - 1145, XP009076235

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-03-3259
    - Y. BENJAMINIY. HOCHBERG, "Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing", J Roy Stat Soc B Met, (19950000), vol. 57, pages 289 - 300
    - S. L. TOPALIAN, "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer", The New England journal of medicine, (20120628), vol. 366, doi:10.1056/NEJMoa1200690, page 2443, XP055098235

DOI:   http://dx.doi.org/10.1056/NEJMoa1200690
    - C. ROBERT, "Pembrolizumab versus Ipilimumab in Advanced Melanoma", England journal of medicine, (20150625), vol. 372, page 2521
    - A. SIVAN, "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy", Science (New York, N.Y., (20151127), vol. 350, doi:10.1126/science.aac4255, page 1084, XP055310361

DOI:   http://dx.doi.org/10.1126/science.aac4255
    - Y. TAUR, "The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation", Blood, (20140814), vol. 124, doi:10.1182/blood-2014-02-554725, page 1174, XP055252479

DOI:   http://dx.doi.org/10.1182/blood-2014-02-554725
    - R. DAILLERE et al., "Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects", Immunity, (20161018), vol. 45, page 931
    - N. IIDA, "Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment", Science (New York, N.Y., (20131122), vol. 342, doi:10.1126/science.1240527, page 967, XP055110345

DOI:   http://dx.doi.org/10.1126/science.1240527
    - K. ATARASHI, "Induction of colonic regulatory T cells by indigenous Clostridium species", Science (New York, N.Y., (20110121), vol. 331, doi:10.1126/science.1198469, page 337, XP055178447

DOI:   http://dx.doi.org/10.1126/science.1198469
    - J. L. ROUNDS. K. MAZMANIAN, "Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota", Proceedings of the National Academy, (20100606), vol. 107, page 12204
    - N. GEVA-ZATORSKY et al., "Mining the Human Gut Microbiota for Immunomodulatory Organisms", Cell, (20170223), vol. 168, doi:10.1016/j.cell.2017.01.022, page 928, XP029932434

DOI:   http://dx.doi.org/10.1016/j.cell.2017.01.022
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.